Related Experiment Video

Updated: Nov 4, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.5K

MicroRNA-181a Is Involved in Methamphetamine Addiction Through the ERAD Pathway

Yujing Wang1, Tao Wei1, Wei Zhao1

  • 1School of Mental Health, Bengbu Medical College, Bengbu, China.

Frontiers in Molecular Neuroscience
|May 24, 2021
PubMed

Insights

MicroRNA-181a (miR-181a) may indirectly cause methamphetamine (METH) addiction by affecting endoplasmic reticulum-associated protein degradation (ERAD). This impacts GABAAα1 levels, a key factor in METH addiction.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Addiction Research

Background:

  • MicroRNA (miRNA) regulation is implicated in methamphetamine (METH) addiction.
  • Previous research linked miR-181a to METH addiction, but mechanisms were unclear.
  • Endoplasmic reticulum-associated protein degradation (ERAD) and GABAAα1 were previously shown to be involved in METH addiction.

Purpose of the Study:

  • To investigate the role of miR-181a in METH addiction.
  • To elucidate the mechanism by which miR-181a influences GABAAα1 and ERAD in the context of METH addiction.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for gene expression analysis.
  • Bioinformatics analysis to predict and validate regulatory pathways.
  • Integration of previous findings on ERAD and GABAAα1 in METH addiction.

Main Results:

  • miR-181a was found to be indirectly associated with METH addiction.
  • miR-181a appears to regulate the downregulation of GABAAα1.
  • The mechanism involves the regulation of ERAD pathways by miR-181a.

Conclusions:

  • miR-181a plays an indirect role in METH addiction.
  • The regulation of ERAD by miR-181a contributes to GABAAα1 downregulation.
  • Understanding this pathway offers potential therapeutic targets for METH addiction.
Keywords:
GABAAα1addictionendoplasmic reticulum-associated protein degradationmethamphetaminemiR-181a

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.7K
Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence09:54

Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence

Published on: March 8, 2020

5.4K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.7K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
460
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.5K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
869
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.6K